Business Wire

LUMA Vision Announces $22 Million in New Financing to Secure FDA Approval and Advance Development of 4D Cardiac Imaging and Navigation Platform

DUBLIN & MUNICH--(BUSINESS WIRE)--LUMA Vision, developer of a novel four-dimensional (4D) cardiac imaging and navigation platform, today announced a total of $22 million in new financing for the ...
MobiHealthNews

4D cardiac imaging company LUMA Vision secures $22M

LUMA Vision, maker of a 4D cardiac imaging and navigation platform that uses machine learning, announced it secured $22 million in Series A3 financing. The round was led by existing investors ABV Uni ...
BioWorld

Luma raises $22M for 4D cardiac imaging and navigation platform

Luma Vision Ltd. raised $22 million in financing that will allow the company to secure U.S. FDA approval and prepare for commercialization of its 4D cardiac imaging technology platform, Verafeye. The ...
Yahoo Finance

LUMA Vision Expands Clinical Use of VERAFEYE™ in Guiding AF Ablations and Completes Key 510k Submission.

DUBLIN, March 19, 2026 /PRNewswire/ -- LUMA Vision, a leader in cardiac 4D imaging and navigation, today announces the expansion of its clinical program with the first patient enrolments in two ...
Yahoo Finance

LUMA Vision to Showcase VERAFEYE 4D Imaging Platform at HRS 2026, Signaling a New Foundation for EP Guidance

DUBLIN, April 21, 2026 /PRNewswire/ -- LUMA Vision, a leader in real-time 4D cardiac imaging and navigation, today announced its participation in the Heart Rhythm Society Annual Meeting (HRS 2026) in ...
PR Newswire

Precision Redefined: LUMA Vision Completes VERAFEYE™ 4D-Guided Persistent AF Ablations, Demonstrating a Significant Advancement in Simplifying Image-Guided Cardiac Care

DUBLIN, Jan. 7, 2026 /PRNewswire/ -- LUMA Vision Ltd., a leader in cardiac 4D navigation and imaging, today announced the successful completion of 15 VERAFEYE™-guided persistent atrial fibrillation ...